WELLBUTRIN

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Germany, Hong Kong SAR China, Israel, Italy, Malta, Mexico, Netherlands, Poland, Singapore, South Africa, Turkey.

Active ingredients

The drug WELLBUTRIN contains one active pharmaceutical ingredient (API):

1	Bupropion UNII ZG7E5POY8O - BUPROPION HYDROCHLORIDE
	Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.
	Read more about Bupropion

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
WELLBUTRIN SR Sustained‑release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
WELLBUTRIN XL Extended-release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX	Other antidepressants	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants
Discover more medicines within N06AX
N06AX12	Bupropion	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510608601119319, 510611901111313, 510611902116319, 510611903112317, 510611904119315
CA	Health Products and Food Branch	02275090, 02275104
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	12541043, 14317640
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28817-04-09, 28818-04-09
HK	Department of Health Drug Office	52125, 58253, 58371
HR	Agencija za lijekove i medicinske proizvode	HR-H-157768861, HR-H-345088727
IL	מִשְׂרַד הַבְּרִיאוּת	6240, 6241
IT	Agenzia del Farmaco	037685029, 049440011
MT	Medicines Authority	MA192/02301, MA192/02302, PI908/25701A, PI908/25702A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	354M98
NL	Z-Index G-Standaard, PRK	82880, 82899
PL	Rejestru Produktów Leczniczych	100175245, 100175251, 100395580, 100397773, 100411148, 100411941, 100418771, 100425707, 100425794, 100426546, 100431079, 100432618, 100432950, 100433150, 100433173, 100433180, 100437248, 100446773, 100447360, 100447376, 100457152, 100457184, 100462580, 100463158, 100465684
SG	Health Sciences Authority	10983P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522032815, 8699522032846
US	FDA, National Drug Code	0173-0135, 0173-0722, 0173-0947, 0187-0730, 0187-0731
ZA	Health Products Regulatory Authority	34/1.2/0266, 41/1.2/0371, 41/1.2/0372